查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404711

靜脈注射液市場規模、佔有率、趨勢分析報告：按產品、按營養素、按地區、細分市場預測，2024-2030 年

Intravenous Solutions Market Size, Share & Trends Analysis Report By Product (TPN, PPN), By Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids) By Region (Asia Pacific, North America), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 114 Pages | 商品交期: 2-10個工作天內

價格

靜脈注射解決方案市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球靜脈注射解決方案市場規模預計將達到220億美元，預測期內複合年成長率為8%。

早產在印度和中國等新興國家尤其普遍，預計將在預測期內推動市場成長。據世界衛生組織稱，十分之一的嬰兒早產，這是全世界關注的問題。因此，新興國家早產發生率較高、醫療基礎設施改善、醫療成本上升和患者意識預計將在預測期內作為市場促進因素產生重大影響。

腸外脂肪乳化的使用是基於各權威機構對降低早產死亡率的廣泛關注。截至2021年，美國的早產率約為10.5%。此外，每年因早產造成的社會和經濟成本估計為 252 億美元。因此，大量生產後需要補充營養的新生兒預計將在預測期內推動市場需求。

此外，還有幾項研究證明對患有營養不良問題的患者使用腸外營養是合理的，這些問題在大流行期間有所增加，從而導致市場成長。例如，發表在《營養與飲食學會雜誌》上的一篇論文發現，許多入住 ICU 接受 COVID-19 治療的患者患有急性營養不良。因此，預計疫情期間腸外營養產品的市場使用量將會增加。

據報道，某些微量營養素和維生素的缺乏在 COVID-19 陽性患者中很常見且有害。因此，建議這些患者靜脈注射以滿足建議的用餐攝取量。對於 COVID-19 患者，醫生和營養專家更喜歡腸外營養而不是經腸營養。這是因為經腸營養特別需要放置鼻胃管，這會干擾為 COVID-19 患者提供的非侵入性通氣。由於誤吸營養液和營養不良的風險增加，住院的 COVID-19 患者擴大採用腸外營養。

靜脈注射解決方案市場報告亮點

  • 到 2023 年，全腸外營養 (TPN) 領域預計將佔據 66.3% 的主導市場佔有率，並在預測期內呈現最高成長率（複合年成長率為 8.2%）。 TPN 涉及透過靜脈注射 (IV) 技術給藥一套全面的營養物質。
  • 2023年，單給藥胺基酸溶液領域將引領市場，佔31.6%的主要佔有率。研究表明，單給藥氨基酸提供了完整的蛋白質來源，可以輕鬆地與其他腸胃外製劑一起客製化，並且易於給藥。
  • Assure Infusions, Inc. 宣布投資 2,000 萬美元在佛羅裡達州巴托建設先進的製造工廠，以解決美國輸液液的供需缺口。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章靜脈溶液市場變數和趨勢

  • 靜脈注射解決方案市場的系統展望
    • 附隨市場前景
  • 市場動態
    • 市場促進因素影響分析
    • 市場抑制因素分析
  • 法律規範
    • 標準和合規性
    • 贖回場景
  • COVID-19 大流行的影響
  • 產業分析工具
    • 波特的分析
    • 宏觀經濟分析

第4章靜脈注射解決方案市場：產品分析

  • 2023年及2030年產品變化分析及市場佔有率
  • 依產品
  • 全腸外營養
    • 完整腸外營養市場，2018-2030
  • 週邊腸外營養
    • 週邊腸外營養市場，2018-2030

第5章靜脈注射液市場：營養分析

  • 2023年及2030年營養成分變化分析及市場佔有率
  • 按營養成分
  • 碳水化合物
    • 碳水化合物市場，2018-2030
  • 單劑量氨基酸給藥
    • 單劑量氨基酸給藥市場，2018-2030
  • 維生素和礦物質
    • 維生素和礦物質，2018-2030
  • 腸外脂肪乳化
    • 腸外脂肪乳化，2018-2030
  • 其他
    • 其他市場，2018-2030

第6章 靜脈注射液市場：區域估計與趨勢分析

  • 靜脈注射解決方案市場：區域展望
  • 北美洲
    • 2018-2030 年北美靜脈注射液市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030 年歐洲靜脈注射溶液市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太地區靜脈注射解決方案市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲靜脈注射溶液市場估計與預測
    • 墨西哥
    • 巴西
    • 阿根廷
  • 中東和非洲 (MEA)
    • 2018-2030 年中東和非洲靜脈注射溶液市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章競爭分析

  • 公司分類
    • Fresenius Kabi AG
    • Pfizer Inc.
    • Otsuka Pharmaceutical Co. Ltd.
    • Baxter, B. Braun Melsungen AG
    • Vifor Pharma Management Ltd.
    • JW Life Science
  • Participants'Overview
  • 財務績效
  • 產品基準評效
  • 市場參與企業分類
    • 熱圖分析
  • 2022 年公司市場佔有率分析
  • 策略規劃
    • 併購
    • 產品發表會
    • 夥伴關係與協作
    • 產品核准
    • 擴張
    • 其他

第8章分析師的觀點

Product Code: GVR-1-68038-137-5

Intravenous Solutions Market Growth & Trends:

The global intravenous solutions market size is expected to reach USD 22.0 billion by 2030, registering a CAGR of 8% during the forecast period, according to a new report by Grand View Research, Inc. The high prevalence of preterm births, especially in emerging economies such as India and China, is expected to drive market growth during the forecast period. According to WHO, 1 in 10 babies are born preterm, and this is a global concern. Thus, the high incidence of preterm births in emerging economies, improved healthcare infrastructure, and growing healthcare expenditure & patient awareness are expected to be high impact rendering drivers of the market during the forecast period.

The use of parenteral lipid emulsions is driven by the extensive focus of various authorities to limit preterm birth mortality. As of 2021, the preterm birth rate in the U.S. was about 10.5%. Moreover, the annual societal, and economic cost was estimated at USD 25.2 billion for preterm births. Hence, the presence of many neonates requiring supplementary postbirth nutrition is expected to boost the market demand over the forecast period.

In addition, several studies justify the use of parenteral nutrition for patients suffering from malnutrition problems, which increased during the pandemic, leading to market growth. For instance, according to an article published in the Journal of the Academy of Nutrition and Dietetics, many patients admitted to the ICU for COVID-19 treatment suffer from acute malnourishment. Hence, the usage of parenteral nutrition products is expected to increase in the market during the pandemic.

In COVID-19-positive patients, high deficiency of specific micronutrients and vitamins has been reported to be detrimental. Thus, intravenous administration is recommended in such patients to meet the recommended dietary intake. Physicians and nutrition specialists preferred parenteral nutrition over enteral nutrition in COVID-19 patients since enteral nutrition specifically requires the setup of nasogastric tubes, which hampers the noninvasive ventilation provided to COVID-19 patients. The increased risk of nutritional solution aspiration and underfeeding in hospitalized patients for COVID-19 has led to increased adoption of parenteral nutrition.

Intravenous Solutions Market Report Highlights:

  • In 2023, the Total Parenteral Nutrition (TPN) segment held a dominant market share of 66.3% and is projected to experience the highest growth rate (CAGR of 8.2%) during the forecast period. TPN involves administering a comprehensive set of nutrients through an intravenous (IV) technique
  • In 2023, the market was led by the single-dose amino acid solution segment, holding a significant share of 31.6%. Studies have shown that single-dose amino acids offer a complete protein source, are easily customizable with other parenteral formulations, and are straightforward to administer
  • In 2023, North America held a dominant market share of 41%, credited to key players, favorable regulations, and strong reimbursement in countries like the U.S. Assure Infusions, Inc. announced a USD 20 million investment to build an advanced manufacturing facility in Bartow, Florida, addressing the IV solutions demand-supply gap in the U.S.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Product Segment
      • 1.1.1.2 Nutrient Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 GVR's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
      • 1.9.1.1 Research Scope And Assumptions
  • 1.10 List Of Secondary Sources
  • 1.11 List Of Primary Sources
  • 1.12 List Of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape

Chapter 3 Intravenous Solutions Market Variables And Trends

  • 3.1 Intravenous Solutions Market Lineage Outlook
    • 3.1.1 Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Impact Analysis
      • 3.2.1.1 Growing Number Of Premature Births
      • 3.2.1.2 Increasing Incidence Of Cancer
      • 3.2.1.3 Increasing Risk Of Malnutrition
      • 3.2.1.4 Growing Geriatric Population
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Shortage Of Parenteral Nutrition Products
      • 3.2.2.2 Increased Use Of Enteral Nutrition
      • 3.2.2.3 High Risk Of Infections
  • 3.3 Regulatory Framework
    • 3.3.1 Standards And Compliances
      • 3.3.1.1 North America
      • 3.3.1.2 Europe
      • 3.3.1.3 Apac
      • 3.3.1.4 Latin America
      • 3.3.1.5 Mea
    • 3.3.2 Reimbursement Scenario
      • 3.3.2.1 U.S.
      • 3.3.2.2 Canada
      • 3.3.2.3 Germany
      • 3.3.2.4 UK
      • 3.3.2.5 Japan
      • 3.3.2.6 Australia
      • 3.3.2.7 China
  • 3.4 Impact Of Covid-19 Pandemic
  • 3.5 Industry Analysis Tools
    • 3.5.1 Porter's Analysis
    • 3.5.2 Macroeconomic Analysis

Chapter 4 Intravenous Solutions Market: Product Analysis

  • 4.1 Product Movement Analysis & Market Share, 2023 & 2030
  • 4.2 Intravenous Solutions Market Estimates & Forecast, By Product (Revenue In USD Million And Volume In Thousand Units)
  • 4.3 Total Parenteral Nutrition
    • 4.3.1 Total Parenteral Nutrition Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 4.4 Peripheral Parenteral Nutrition
    • 4.4.1 Peripheral Parenteral Nutrition Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)

Chapter 5 Intravenous Solutions Market: Nutrients Analysis

  • 5.1 Nutrients Movement Analysis & Market Share, 2023 & 2030
  • 5.2 Intravenous Solutions Market Estimates & Forecast, By Nutrients (Revenue In USD Million And Volume In Thousand Units)
  • 5.3 Carbohydrates
    • 5.3.1 Carbohydrates Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 5.4 Single-dose Amino Acid Solution
    • 5.4.1 Single-dose Amino Acid Solution Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 5.5 Vitamins & Minerals
    • 5.5.1 Vitamins & Minerals, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 5.6 Parenteral Lipid Emulsion
    • 5.6.1 Parenteral Lipid Emulsion, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 5.7 Others
    • 5.7.1 Others Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)

Chapter 6 Intravenous Solutions Market: Regional Estimates & Trend Analysis

  • 6.1 Intravenous Solutions Market: Regional Outlook
  • 6.2 North America
    • 6.2.1 North America Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.2.2 U.S.
      • 6.2.2.1 Key Country Dynamics
      • 6.2.2.2 U.S. Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.2.3 Canada
      • 6.2.3.1 Key Country Dynamics
      • 6.2.3.2 Canada Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 6.3 Europe
    • 6.3.1 Europe Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.2 UK
      • 6.3.2.1 Key Country Dynamics
      • 6.3.2.2 UK Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.3 Germany
      • 6.3.3.1 Key Country Dynamics
      • 6.3.3.2 Germany Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.4 France
      • 6.3.4.1 Key Country Dynamics
      • 6.3.4.2 France Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.5 Italy
      • 6.3.5.1 Key Country Dynamics
      • 6.3.5.2 Italy Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.6 Spain
      • 6.3.6.1 Key Country Dynamics
      • 6.3.6.2 Spain Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.7 Denmark
      • 6.3.7.1 Key Country Dynamics
      • 6.3.7.2 Denmark Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.8 Sweden
      • 6.3.8.1 Key Country Dynamics
      • 6.3.8.2 Sweden Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.9 Norway
      • 6.3.9.1 Key Country Dynamics
      • 6.3.9.2 Norway Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.4.2 Japan
      • 6.4.2.1 Key Country Dynamics
      • 6.4.2.2 Japan Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.4.3 China
      • 6.4.3.1 Key Country Dynamics
      • 6.4.3.2 China Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.4.4 India
      • 6.4.4.1 Key Country Dynamics
      • 6.4.4.2 India Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.4.5 Australia
      • 6.4.5.1 Key Country Dynamics
      • 6.4.5.2 Australia Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.4.6 South Korea
      • 6.4.6.1 Key Country Dynamics
      • 6.4.6.2 South Korea Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.4.7 Thailand
      • 6.4.7.1 Key Country Dynamics
      • 6.4.7.2 Thailand Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 6.5 Latin America
    • 6.5.1 Latin America Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.5.2 Mexico
      • 6.5.2.1 Key Country Dynamics
      • 6.5.2.2 Mexico Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.5.3 Brazil
      • 6.5.3.1 Key Country Dynamics
      • 6.5.3.2 Brazil Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.5.4 Argentina
      • 6.5.4.1 Key Country Dynamics
      • 6.5.4.2 Argentina Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 6.6 Middle East & Africa (Mea)
    • 6.6.1 Mea Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.6.3 South Africa
      • 6.6.3.1 Key Country Dynamics
      • 6.6.3.2 South Africa Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.6.4 Saudi Arabia
      • 6.6.4.1 Key Country Dynamics
      • 6.6.4.2 Saudi Arabia Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.6.5 UAE
      • 6.6.5.1 Key Country Dynamics
      • 6.6.5.2 UAE Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.6.6 Kuwait
      • 6.6.6.1 Key Country Dynamics
      • 6.6.6.2 Kuwait Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)

Chapter 7 Competitive Analysis

  • 7.1 Company Categorization
    • 7.1.1 Fresenius Kabi AG
    • 7.1.2 Pfizer Inc.
    • 7.1.3 Otsuka Pharmaceutical Co. Ltd.
    • 7.1.4 Baxter, B. Braun Melsungen AG
    • 7.1.5 Vifor Pharma Management Ltd.
    • 7.1.6 JW Life Science
  • 7.2 Participants' Overview
  • 7.3 Financial Performance
  • 7.4 Product Benchmarking
  • 7.5 Market Participant Categorization
    • 7.5.1 Heat Map Analysis
  • 7.6 Company Market Share Analysis, 2022
  • 7.7 Strategy Mapping
    • 7.7.1 Mergers & Acquisitions
    • 7.7.2 Product Launch
    • 7.7.3 Partnerships & Collaborations
    • 7.7.4 Product Approvals
    • 7.7.5 Expansion
    • 7.7.6 Others

Chapter 8 Analyst Perspective

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Intravenous solutions market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape
  • Fig. 12 Intravenous solutions market dynamics
  • Fig. 13 Preterm birth rates in the U.S., 2011 to 2030
  • Fig. 14 Number of undernourished people in the world, 2015 - 2020 (Million and Percentage)
  • Fig. 15 Intravenous solutions market: PORTER's analysis
  • Fig. 16 Intravenous solutions market: PESTEL analysis
  • Fig. 17 Intravenous solutions market: by product: key takeaways
  • Fig. 18 Intravenous solutions market, by product: market share, 2023 & 2030
  • Fig. 19 Total parenteral nutrition market, 2018 - 2030 (USD Million)
  • Fig. 20 Peripheral parenteral nutrition market, 2018 - 2030 (USD Million)
  • Fig. 21 Intravenous solutions market, by end-use: key takeaways
  • Fig. 22 Intravenous solutions market, by nutrients: market share, 2023 & 2030
  • Fig. 23 Carbohydrates market, 2018 - 2030 (USD Million)
  • Fig. 24 Single dose amino acid solution market, 2018 - 2030 (USD Million)
  • Fig. 25 Vitamins and minerals, 2018 - 2030 (USD Million)
  • Fig. 26 Parenteral lipid emulsion, 2018 - 2030 (USD Million)
  • Fig. 27 Others market, 2018 - 2030 (USD Million)
  • Fig. 28 Intravenous solutions market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 29 Regional marketplace: key takeaways
  • Fig. 30 Regional marketplace: key takeaways
  • Fig. 31 North America intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 U.S. intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 Canada intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 UK intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Germany intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 France intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Italy intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Spain intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Denmark intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Sweden intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Norway intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Japan intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 China intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 India intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Australia intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 South Korea intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Thailand intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Mexico intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Brazil intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Argentina intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 73 MEA intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 South Africa intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Saudi Arabia intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 UAE intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Kuwait intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 82 Key company categorization
  • Fig. 83 Heat map analysis
  • Fig. 84 Company market share analysis, 2023
  • Fig. 85 Strategy mapping